Responses
Scientific Abstracts
Oral Presentations
Abstract Session: Molecules – small and smart
OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders
Compose a Response to This Article
Other responses
No responses have been published for this article.